Lilia Golovko

Dr. Lilia Golovko

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2025 in Fishes
Verified
Journal Article
Open access
PDF file
GMGennady Matishov
Gennady Matishov
Besarion MeskhiBesarion Meskhi
Besarion Meskhi
Dmitry RudoyDmitry Rudoy
Dmitry Rudoy
AOAnastasiya Olshevskaya
Anastasiya Olshevskaya
Viktoriya ShevchenkoViktoriya Shevchenko
Viktoriya Shevchenko
STSvetlana Teplyakova
Svetlana Teplyakova
In the present study, literature information on the functioning of the biofloc technology (BFT) system, its components, the state of the organism of hydrobionts, and water quality is analyzed. It is shown that this technology allows reducing financial costs for water treatment by 30%, increasing the efficiency of protein assimilation in the feed composition by two times, and creating a high-protein substrate, which can be further used as a component of feed for aquaculture. The BFT contains a large number of microorganisms, including photoautotrophic microorganisms (algae), chemoautotrophic microorganisms (nitrifying bacteria), and heterotrophic microorganisms (fungi, infusoria, protozoa, and zooplankton). This technology contributes to the improvement in water quality, aquaculture productivity, and hydrobionts. Despite the higher initial costs, BFT can yield higher economic profits. In this paper, the authors summarize data from many recent studies devoted to BFT. Based on the analysis of a number of studies, it can be concluded that this technology has a high potential for scaling up in industrial aquaculture.

7 July 2025 in Animals
Verified
Journal Article
Open access
PDF file
EPEvgeniya Prazdnova
Evgeniya Prazdnova
MMMaria Sergeevna Mazanko
Maria Sergeevna Mazanko
Viktoriya ShevchenkoViktoriya Shevchenko
Viktoriya Shevchenko
RSRadomir Viktorovich Skripnichenko
Radomir Viktorovich Skripnichenko
MKMaksim Kulikov
Maksim Kulikov
Dmitry RudoyDmitry Rudoy
Dmitry Rudoy
The shift toward plant-based feeds in aquaculture necessitates a search for probiotics to improve the digestibility of such feeds and fish growth. This study characterizes four Bacillus strains for their probiotic potential in carp (Cyprinus carpio). Strains isolated from river sediments underwent in vitro screening for proteolytic/amylolytic activity, antibiotic sensitivity, and biofilm formation. Whole-genome sequencing was performed and functional annotation identified probiotic-related genes. All strains were identified as Bacillus velezensis and harbored genes providing thermal, osmotic, and oxidative stress resistance, alongside enzymes and bioactive metabolite synthesis pathways. Two non-antagonistic strain pairs were solid-phase cultivated on soybeans and incorporated into carp feed (0.1% w/w) for a 76-day trial, and growth metrics and gene expression were analyzed in juvenile fish. Group 1 (strains MT14 + MT42) exhibited a 40.75% higher biomass increase than the control group while Group 2 (strains MT141 + MT142) exhibited a 56.62% higher biomass growth. No significant gene expression changes occurred in juveniles, though MT141 + MT142 transiently modulated fry expression profiles. Therefore, these Bacillus velezensis strains synergistically enhance growth in carp that are fed plant-rich diets, highlighting their viability as aquaculture probiotics.

30 March 2021 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
LGLilia Golovko
Lilia Golovko
ASAndrey V. Safronenko
Andrey V. Safronenko
EGElena V. Gantsgorn
Elena V. Gantsgorn
NSNataliya V. Sukhorukova
Nataliya V. Sukhorukova
AKAndrey V. Kapliev
Andrey V. Kapliev
Introduction: The goal of our study was to develop a risk-oriented algorithm for the combined use of hemostatics and anticoagulants in patients after total arthroplasty of the knee or hip joints to reduce the risk of thrombohemorrhagic complications. Materials and methods: We performed a retrospective study (n=253). In group (Gr.) 1, the time interval (TI) between the administration of hemostatic and anticoagulant prophylaxis was ≤17 hours (n=145; 57.31%), and in Gr. 2 – 18-24 hours (n=108; 42.68%). We analyzed the influence of different factors on the development of thrombosis and bleeding cases after the operation. Results and discussion: Thrombohemorrhagic complications were observed in 27 (10.67%) patients. Thrombosis in Gr. 1 was associated with the use of tranexamic acid, and were recorded 2.2 times more often than in Gr. 2 (p75 years, for women – an initially low level of international normalized ratio, and activated partial thromboplastin time (APTT) (p75 years, among men and women – an increased preoperative level of APTT, for women – a decreased level of fibrinogen and platelets (p<0.05). Conclusion: To prevent thrombosis and bleeding after arthroplasty of large joints, the TI between the use of hemostatics and anticoagulants should be at least 18 hours, especially in patients with the above risk factors, in particular, when using tranexamic acid and low molecular weight heparins.

14 October 2020 in Kuban Scientific Medical Bulletin
Verified
Journal Article
Open access
PDF file
LGLilia Golovko
Lilia Golovko
ASA. V. Safronenko
A. V. Safronenko
NSN. V. Sukhorukova
N. V. Sukhorukova
EGE. V. Gantsgorn
E. V. Gantsgorn
Background. Anticoagulant and haemostatic drugs are used to prevent thrombosis and bleeding after arthroplasty. Combined therapy with these divergent agents, especially in comorbid patients, is not regulated in relevant clinical guidelines and may lead to a reduced effi cacy.Objectives. Assessment of the effect of time interval (TI) in variant combined settings of haemostatic and anticoagulant drugs and concomitant pathology on the development of thrombohaemorrhagic complications after hip or knee arthroplasty.Мethods. In a retrospective study, we analysed patients’ somatic status, haemostatic and anticoagulant drug regimes and their combined impact on the development of thrombohaemorrhagic complications in early postoperative period.Results. We analysed 253 case histories with total replacement of main lower limb joints. Two cohorts were defi ned with respect to TI between haemostatic and anticoagulant drug applications. TI was 17 h or less (n = 145; 57.31%) in cohort 1 and 18–24 h (n = 108; 42.68%) — in cohort 2. A total of 29 drug combinations were tested. Thrombohaemorrhagic complications were observed in 27 (10.67%) patients, with 22 (81.48%) in cohort 1. Thromboses in regimes with tranexamic acid developed in cohort 1 (p = 0.038) at a 2.2-folds higher rate than in cohort 2 (p < 0.05). Thrombosis development was infl uenced by grade 2 obesity (relative risk = 8.75, p = 0.037), type 2 diabetes (relative risk = 21, p = 0.00001), myocardial infarction (relative risk = 16.875, p = 0.00002), venous pathology (relative risk = 8.1, p = 0.045) and the patient’s age over 75 (relative risk = 6.8, p = 0.029). Age over 75 years increased the risk of bleeding by a factor of 12 (relative risk = 12, p = 0.015).Conclusion. After main joint arthroplasty, differential measures to prevent thrombohaemorrhagic complications include a minimal 18-h TI between haemostatic and anticoagulant agent applications, especially in tranexamic acid regimes, and the consideration of concomitant risk factors, such as grade 2 obesity, type 2 diabetes, myocardial infarction in history, venous pathology and age over 75 years.

12 August 2020 in Kazan medical journal
Verified
Journal Article
Open access
PDF file
LGL S Golovko
L S Golovko
ASA V Safronenko
A V Safronenko
EGE V Gantsgorn
E V Gantsgorn
NSN V Sukhorukova
N V Sukhorukova
YMY S Maklyakov
Y S Maklyakov
МСМакляков Юрий Степанович
Макляков Юрий Степанович
Aim. To assess the dynamics of coagulation parameters and the influence of its initial values on the development of postoperative thrombohemorrhagic complications in male and female patients undergoing large joint arthroplasty and received combination hemostatic and anticoagulant therapy. Methods. A retrospective analysis of the medical records (n=253) of patients with arthroplasty, were divided into two groups based on the time differences between prescription of hemostatic and anticoagulation therapy. The first group includes 145 patients (57.31%, 112 women and 33 men) with time differences 17 h, and the second group includes 108 patients (42.68%, 78 women and 30 men) with time differences 1824 h. The dynamics of coagulation test results were analyzed, and the influence of its initial value on the risk of postoperative thrombosis or bleeding was assessed. Results. Thrombohemorrhagic complications were recorded in 27 (10.67%) patients, of which 22 (81.48%) were observed in group 1. In the first group, thrombosis developed in regimens with tranexamic acid (p=0.038) with 2.2 times higher incidence than in group 2 (p=0.023). The risk of thrombosis of women in the group 1 was increased by an initially low level of international normalized ratio [relative risk (RR) 13.333, p=0.00032] and activated partial thromboplastin time (RR=5.8, p=0.037). The risk of bleeding in group 1 increased by an increasing preoperative level of activated partial thromboplastin time (RR=18, p=0.0012 and RR=28, p=0.00022, respectively) for all patients and by a decreasing fibrinogen level (RR=23.25, p=0.00065) and platelets count (RR=10.2, p=0.038) for women. Conclusion. To minimize the risks of thrombosis and bleeding after arthroplasty, especially in patients with initial deviations of hemostasis parameters from the norm, and, in particular, when using tranexamic acid as a hemostatic agent, it is recommended to observe the time interval between hemostatic and anticoagulant pharmacotherapy for at least 18 hours.

26 September 2025 in Bulletin of KSAU
Verified
Journal Article
Open access
PDF file
Dmitry RudoyDmitry Rudoy
Dmitry Rudoy
AOAnastasiya Olshevskaya
Anastasiya Olshevskaya
LGLilia Golovko
Lilia Golovko
Viktoriya ShevchenkoViktoriya Shevchenko
Viktoriya Shevchenko
MOMary Odabashyan
Mary Odabashyan
STSvetlana Teplyakova
Svetlana Teplyakova
The aim of the study is to review the literature on the etiological characteristics of pathogens causing infectious processes, possible disease symptoms and the expected outcome of the pathological condition of aquatic organisms. Objectives: primary selection of literature on publicly available electronic bibliographic databases using keywords; analysis of the literature included in the study, its systematization, compilation and processing of the presented information. The literature was taken into account for the period from 2000 to 2024, the study included 76 sources. A brief reference is presented giving a general idea of the Australian red claw crayfish, a description of the pathogens most characteristic of the red claw crayfish. Most of them relate to viral microorganisms, such as white spot syndrome virus, which also affects other crustaceans, bacilliform virus characterized by the presence of rod-shaped virions; a virus similar to the Cherax giardiasis virus (Giardia-like virus), causing digestive disorders. In addition to viruses, red claw crayfish are susceptible to bacterial infections, such as rickettsia-like microorganisms, which can lead to the death of individuals. Among fungal pathogens, Fusarium spp. and Aphanomyces astaci are quite common, the latter being responsible for the development of crayfish plague, a disease with a high risk of mass mortality of aquatic organisms. Based on the results of this study, it can be concluded that there is a significant diversity of pathogens of viral, fungal and bacterial nature that can provoke the death of infected individuals, and with high contagiousness, mass mortality in the population, which will lead to economic losses in the industry and disrupt its sustainable development.